Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 10/20 | 0.43 |
| ▸ | MAPT | P10636 | 10/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL626392 | 0.92 | MAP3K12 (0.44) | MAP3K12MAPTTHRBPOLBLMNA | |
| SCHEMBL624412 | 0.89 | MAP3K12 (0.45) | MAP3K12MAPT | |
| SCHEMBL625019 | 0.88 | MAP3K12 (0.45) | MAP3K12MAPTTHRBPOLBLMNA | |
| SCHEMBL625433 | 0.86 | MAPT (0.43) | MAP3K12MAPTTHRBPOLBLMNA | |
| SCHEMBL625201 | 0.86 | PIK3CA (0.48) | MAP3K12 | |
| SCHEMBL625223 | 0.85 | MAPT (0.49) | MAPTTHRBPOLBLMNATP53 | |
| SCHEMBL625228 | 0.84 | MAP3K12 (0.46) | MAP3K12 | |
| SCHEMBL624866 | 0.82 | PIK3CA (0.46) | MAP3K12MAPTTHRBPOLBLMNA | |
| SCHEMBL625178 | 0.82 | MAPT (0.54) | MAPTTHRBPOLBLMNATP53 | |
| SCHEMBL627411 | 0.82 | MAP3K12 (0.47) | MAP3K12MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |